Article Details
Retrieved on: 2024-05-14 18:04:56
Tags for this article:
Click the tags to see associated articles and topics
Summary
HUB Organoids Holdings B.V. leverages innovative organoid technology to transform drug development, recognized by Frost & Sullivan with a leadership award. This new business model impacts fields like developmental neuroscience and synthetic biology, aligning with the article's tags.
Article found on: www.prnewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here